Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2

Sponsor Class

OTHER 20OTHER_GOV 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Surgical Wound Infection 1Stomach Neoplasms 1Rectal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Oxaliplatin 30Capecitabine 26Fluorouracil 20Irinotecan 19tislelizumab 18apatinib 16Paclitaxel 13Cisplatin 13S 1 (combination) 12Radiotherapy 12Leucovorin 11Bevacizumab 11Laparoscopy 9Drug Therapy 9Cetuximab 9sintilimab 8Endoscopic Mucosal Resection 8Gemcitabine 7Docetaxel 7camrelizumab 6XELOX 6Surgical Procedures, Operative 6Radiation 6Propranolol 6Nivolumab 6Neoadjuvant Therapy 6Immune Checkpoint Inhibitors 6Folfox protocol 6Levoleucovorin 5HMPL-013 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Metronidazole × Gastrointestinal × Clear all
NCT06216639 2024-02-09

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

National Institute of Public Health, Slovenia

Unknown
2,000 enrolled
Gastrointestinal

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT03436719 2019-03-05

Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics.

State Scientific Centre of Coloproctology, Russian Federation

Phase NA Unknown
280 enrolled
Gastrointestinal

Rectal Neoplasms, Surgical Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡